
US-based X-Therma Inc., founded in 2014, specializes in commercial physical and biological R&D.
Founded in 2014, X-Therma Inc. is a US-based company specializing in commercial physical and biological research and development. The company's core mission is to advance regenerative medicine and organ transplantation through a groundbreaking biopreservation platform. X-Therma's products and services focus on preserving cells, tissues, organs, and regenerative medicines, aiming to enable patient access to safe and reliable organs, engineered tissues, and cell therapies by overcoming the barriers of time and distance.
X-Therma has garnered attention for its innovative approach to biopreservation, attracting notable investors and industry experts. Key achievements include the development of a robust preservation platform that significantly extends the viability of transplantable organs. The company's impact is evident in its potential to revolutionize organ transplantation and regenerative medicine, offering new hope for patients requiring these critical medical interventions.
Sylvatica Biotech
sylvaticabio.com

BiomedInnovations
XRad Therapeutics

Therapyx
therapyxinc.com

Xcell Biosciences
xcellbio.com

AgeX Therapeutics

Upkara
upkara.com

Paragonix Technologies

Zenith Technical Innovations

Xylyx Bio
xylyxbio.com
X-Rase RD Development

eGenesis
egenesisbio.com

Endogena Therapeutics

Regenevida
recombinetics.com

Theradaptive
theradaptive.com
Companies similar to X-Therma include Sylvatica Biotech, BiomedInnovations, XRad Therapeutics and Therapyx.
X-Therma was founded in 2014.
X-Therma's headquarters is located in Richmond, CA, US.
X-Therma's most recent funding round was for $13M (USD) in December 2021.
As of Dec 22, 2021, X-Therma has raised a total of $14.5M (USD).
X-Therma has 28 employees as of Feb 5, 2024.